Skip to content

Construction and empirical research of an intelligent management plan for the number of symptoms after lung transplantation based on the dynamic model of symptom management

Construction and empirical research of an intelligent management plan for the number of symptoms after lung transplantation based on the dynamic model of symptom management

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127220
Enrollment
Unknown
Registered
2026-06-26
Start date
2025-12-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complications after lung transplantation

Interventions

control group:routine nursing after lung transplantation
intervention group:Implement a symptom management plan to promptly identify any postoperative symptom issues in patients and report them to the doctor for handling in a timely manner If there is a sym
When fever symptoms occur, physical or drug cooling should be administered, and anti-infection drugs should be adjusted in a timely manner for treatment. A wound appears Pain symptoms should be treate
Observation group:None

Sponsors

Wuxi people’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The first lung transplantation was performed; 2.age >= 18 years old; 3.can communicate normally; 4.Voluntary participation in this study.

Exclusion criteria

Exclusion criteria: 1.Refusal or inability to cooperate with the investigator; 2.patients with severe complications or even death;

Design outcomes

Primary

MeasureTime frame
occurrence oF symptoms;quality of life;

Secondary

MeasureTime frame
complication;adaptation;LOS(length of stay);

Countries

China

Contacts

Public ContactDing Siyan

Wuxi people’s Hospital

1070280742@qq.com+86 510 85351515

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026